August 7, 2007 - BSD Medical Corp. announced that the Centers for Medicare and Medicaid Services (CMS) has proposed an approximate 86 percent increase in the reimbursement rate for all of the CMS codes applicable to the use of BSD cancer treatment systems for hospital outpatient procedures.
The new proposed reimbursement rates will be finalized in November and become effective Jan. 1, 2008. Increases ranging from 14 to 44 percent have also been proposed for freestanding clinics.
BSD Medical develops systems used to deliver hyperthermia therapy to kill cancer directly and increase the effectiveness of companion radiation treatments. According to the company, research also shows promising results from the user of hyperthermia therapy in combination with chemotherapy, and for tumor reduction prior to surgery.
For more information: www.BSDMedical